Ophthalmic manifestations in patients with inflammatory bowel disease: a review

Clinical manifestations of inflammatory bowel disease(IBD) are not locally restricted to the gastrointestinal tract, and a significant portion of patients have involvement of other organs and systems. The visual system is one of the most frequently affected, mainly by inflammatory disorders such as...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:World journal of gastroenterology : WJG 2017-08, Vol.23 (32), p.5836-5848
Hauptverfasser: Troncoso, Leandro Lopes, Biancardi, Ana Luiza, de Moraes, Jr, Haroldo Vieira, Zaltman, Cyrla
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 5848
container_issue 32
container_start_page 5836
container_title World journal of gastroenterology : WJG
container_volume 23
creator Troncoso, Leandro Lopes
Biancardi, Ana Luiza
de Moraes, Jr, Haroldo Vieira
Zaltman, Cyrla
description Clinical manifestations of inflammatory bowel disease(IBD) are not locally restricted to the gastrointestinal tract, and a significant portion of patients have involvement of other organs and systems. The visual system is one of the most frequently affected, mainly by inflammatory disorders such as episcleritis, uveitis and scleritis. A critical review of available literature concerning ocular involvement in IBD, as it appears in Pub Med, was performed. Episcleritis, the most common ocular extraintestinal manifestation(EIM), seems to be more associated with IBD activity when compared with other ocular EIMs. In IBD patients, anterior uveitis has an insidious onset, it is longstanding and bilateral, and not related to the intestinal disease activity. Systemic steroids or immunosuppressants may be necessary in severe ocular inflammation cases, and control of the underlying bowel disease is important to prevent recurrence. Our review revealed that ocular involvement is more prevalent in Crohn’s disease than ulcerative colitis, in active IBD, mainly in the presence of other EIMs. The ophthalmic symptoms in IBD are mainly nonspecific and their relevance may not be recognized by the clinician; most ophthalmic manifestations are treatable, and resolve without sequel upon prompt treatment. A collaborative clinical care team for management of IBD that includes ophthalmologists is central for improvement of quality care for these patients, and it is also cost-effective.
doi_str_mv 10.3748/wjg.v23.i32.5836
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5583569</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cqvip_id>90888889504849555150484851</cqvip_id><sourcerecordid>1941368684</sourcerecordid><originalsourceid>FETCH-LOGICAL-c440t-a72f9b4bbbb06e964a9b8b14c87971fb41781e02361556e9aa746b1b5c405c853</originalsourceid><addsrcrecordid>eNpVUctOwzAQtBCIlsKdE8qRS4rfDw5IqOIlIfUCZ8sOTuMqids4bcTf40KpYC-72p0dj3cAuERwSgSVN8NyMd1iMvUET5kk_AiMMUYqx5LCYzBGEIpcESxG4CzGJYSYEIZPwQjL1IWCj8F8vqr6ytSNL7LGtL50sTe9D23MfJutUunaPmaD76vUKGvTNKYP3Wdmw-Dq7MNHZ6K7zUzWua13wzk4KU0d3cU-T8D748Pb7Dl_nT-9zO5f84JS2OdG4FJZalNA7hSnRllpES2kUAKVliIhkUt6OWIsAYwRlFtkWUEhKyQjE3D3w7va2MZ9FEllZ2q96nxjuk8djNf_J62v9CJsNUt3Ylwlgus9QRfWm_Rr3fhYuLo2rQubqJGiiHDJJU1Q-AMtuhBj58rDMwjqnQ86-aCTDzr5oHc-pJWrv_IOC7-HTwCy56xCu1j7dnHAKCh3oRikkirGGPquJEPkCzYclfQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1941368684</pqid></control><display><type>article</type><title>Ophthalmic manifestations in patients with inflammatory bowel disease: a review</title><source>MEDLINE</source><source>Baishideng "World Journal of" online journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Troncoso, Leandro Lopes ; Biancardi, Ana Luiza ; de Moraes, Jr, Haroldo Vieira ; Zaltman, Cyrla</creator><creatorcontrib>Troncoso, Leandro Lopes ; Biancardi, Ana Luiza ; de Moraes, Jr, Haroldo Vieira ; Zaltman, Cyrla</creatorcontrib><description>Clinical manifestations of inflammatory bowel disease(IBD) are not locally restricted to the gastrointestinal tract, and a significant portion of patients have involvement of other organs and systems. The visual system is one of the most frequently affected, mainly by inflammatory disorders such as episcleritis, uveitis and scleritis. A critical review of available literature concerning ocular involvement in IBD, as it appears in Pub Med, was performed. Episcleritis, the most common ocular extraintestinal manifestation(EIM), seems to be more associated with IBD activity when compared with other ocular EIMs. In IBD patients, anterior uveitis has an insidious onset, it is longstanding and bilateral, and not related to the intestinal disease activity. Systemic steroids or immunosuppressants may be necessary in severe ocular inflammation cases, and control of the underlying bowel disease is important to prevent recurrence. Our review revealed that ocular involvement is more prevalent in Crohn’s disease than ulcerative colitis, in active IBD, mainly in the presence of other EIMs. The ophthalmic symptoms in IBD are mainly nonspecific and their relevance may not be recognized by the clinician; most ophthalmic manifestations are treatable, and resolve without sequel upon prompt treatment. A collaborative clinical care team for management of IBD that includes ophthalmologists is central for improvement of quality care for these patients, and it is also cost-effective.</description><identifier>ISSN: 1007-9327</identifier><identifier>EISSN: 2219-2840</identifier><identifier>DOI: 10.3748/wjg.v23.i32.5836</identifier><identifier>PMID: 28932076</identifier><language>eng</language><publisher>United States: Baishideng Publishing Group Inc</publisher><subject>Gastroenterologists - organization &amp; administration ; Immunosuppressive Agents - therapeutic use ; Inflammatory Bowel Diseases - complications ; Inflammatory Bowel Diseases - drug therapy ; Inflammatory Bowel Diseases - epidemiology ; Intersectoral Collaboration ; Ophthalmologists - organization &amp; administration ; Patient Care Team - organization &amp; administration ; Prevalence ; Recurrence ; Review ; Scleritis - drug therapy ; Scleritis - epidemiology ; Scleritis - etiology ; Uveitis - drug therapy ; Uveitis - epidemiology ; Uveitis - etiology</subject><ispartof>World journal of gastroenterology : WJG, 2017-08, Vol.23 (32), p.5836-5848</ispartof><rights>The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. 2017</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c440t-a72f9b4bbbb06e964a9b8b14c87971fb41781e02361556e9aa746b1b5c405c853</citedby><cites>FETCH-LOGICAL-c440t-a72f9b4bbbb06e964a9b8b14c87971fb41781e02361556e9aa746b1b5c405c853</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/84123X/84123X.jpg</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583569/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583569/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28932076$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Troncoso, Leandro Lopes</creatorcontrib><creatorcontrib>Biancardi, Ana Luiza</creatorcontrib><creatorcontrib>de Moraes, Jr, Haroldo Vieira</creatorcontrib><creatorcontrib>Zaltman, Cyrla</creatorcontrib><title>Ophthalmic manifestations in patients with inflammatory bowel disease: a review</title><title>World journal of gastroenterology : WJG</title><addtitle>World Journal of Gastroenterology</addtitle><description>Clinical manifestations of inflammatory bowel disease(IBD) are not locally restricted to the gastrointestinal tract, and a significant portion of patients have involvement of other organs and systems. The visual system is one of the most frequently affected, mainly by inflammatory disorders such as episcleritis, uveitis and scleritis. A critical review of available literature concerning ocular involvement in IBD, as it appears in Pub Med, was performed. Episcleritis, the most common ocular extraintestinal manifestation(EIM), seems to be more associated with IBD activity when compared with other ocular EIMs. In IBD patients, anterior uveitis has an insidious onset, it is longstanding and bilateral, and not related to the intestinal disease activity. Systemic steroids or immunosuppressants may be necessary in severe ocular inflammation cases, and control of the underlying bowel disease is important to prevent recurrence. Our review revealed that ocular involvement is more prevalent in Crohn’s disease than ulcerative colitis, in active IBD, mainly in the presence of other EIMs. The ophthalmic symptoms in IBD are mainly nonspecific and their relevance may not be recognized by the clinician; most ophthalmic manifestations are treatable, and resolve without sequel upon prompt treatment. A collaborative clinical care team for management of IBD that includes ophthalmologists is central for improvement of quality care for these patients, and it is also cost-effective.</description><subject>Gastroenterologists - organization &amp; administration</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Inflammatory Bowel Diseases - complications</subject><subject>Inflammatory Bowel Diseases - drug therapy</subject><subject>Inflammatory Bowel Diseases - epidemiology</subject><subject>Intersectoral Collaboration</subject><subject>Ophthalmologists - organization &amp; administration</subject><subject>Patient Care Team - organization &amp; administration</subject><subject>Prevalence</subject><subject>Recurrence</subject><subject>Review</subject><subject>Scleritis - drug therapy</subject><subject>Scleritis - epidemiology</subject><subject>Scleritis - etiology</subject><subject>Uveitis - drug therapy</subject><subject>Uveitis - epidemiology</subject><subject>Uveitis - etiology</subject><issn>1007-9327</issn><issn>2219-2840</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVUctOwzAQtBCIlsKdE8qRS4rfDw5IqOIlIfUCZ8sOTuMqids4bcTf40KpYC-72p0dj3cAuERwSgSVN8NyMd1iMvUET5kk_AiMMUYqx5LCYzBGEIpcESxG4CzGJYSYEIZPwQjL1IWCj8F8vqr6ytSNL7LGtL50sTe9D23MfJutUunaPmaD76vUKGvTNKYP3Wdmw-Dq7MNHZ6K7zUzWua13wzk4KU0d3cU-T8D748Pb7Dl_nT-9zO5f84JS2OdG4FJZalNA7hSnRllpES2kUAKVliIhkUt6OWIsAYwRlFtkWUEhKyQjE3D3w7va2MZ9FEllZ2q96nxjuk8djNf_J62v9CJsNUt3Ylwlgus9QRfWm_Rr3fhYuLo2rQubqJGiiHDJJU1Q-AMtuhBj58rDMwjqnQ86-aCTDzr5oHc-pJWrv_IOC7-HTwCy56xCu1j7dnHAKCh3oRikkirGGPquJEPkCzYclfQ</recordid><startdate>20170828</startdate><enddate>20170828</enddate><creator>Troncoso, Leandro Lopes</creator><creator>Biancardi, Ana Luiza</creator><creator>de Moraes, Jr, Haroldo Vieira</creator><creator>Zaltman, Cyrla</creator><general>Baishideng Publishing Group Inc</general><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>~WA</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20170828</creationdate><title>Ophthalmic manifestations in patients with inflammatory bowel disease: a review</title><author>Troncoso, Leandro Lopes ; Biancardi, Ana Luiza ; de Moraes, Jr, Haroldo Vieira ; Zaltman, Cyrla</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c440t-a72f9b4bbbb06e964a9b8b14c87971fb41781e02361556e9aa746b1b5c405c853</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Gastroenterologists - organization &amp; administration</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Inflammatory Bowel Diseases - complications</topic><topic>Inflammatory Bowel Diseases - drug therapy</topic><topic>Inflammatory Bowel Diseases - epidemiology</topic><topic>Intersectoral Collaboration</topic><topic>Ophthalmologists - organization &amp; administration</topic><topic>Patient Care Team - organization &amp; administration</topic><topic>Prevalence</topic><topic>Recurrence</topic><topic>Review</topic><topic>Scleritis - drug therapy</topic><topic>Scleritis - epidemiology</topic><topic>Scleritis - etiology</topic><topic>Uveitis - drug therapy</topic><topic>Uveitis - epidemiology</topic><topic>Uveitis - etiology</topic><toplevel>online_resources</toplevel><creatorcontrib>Troncoso, Leandro Lopes</creatorcontrib><creatorcontrib>Biancardi, Ana Luiza</creatorcontrib><creatorcontrib>de Moraes, Jr, Haroldo Vieira</creatorcontrib><creatorcontrib>Zaltman, Cyrla</creatorcontrib><collection>中文科技期刊数据库</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>中文科技期刊数据库-7.0平台</collection><collection>中文科技期刊数据库- 镜像站点</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>World journal of gastroenterology : WJG</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Troncoso, Leandro Lopes</au><au>Biancardi, Ana Luiza</au><au>de Moraes, Jr, Haroldo Vieira</au><au>Zaltman, Cyrla</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ophthalmic manifestations in patients with inflammatory bowel disease: a review</atitle><jtitle>World journal of gastroenterology : WJG</jtitle><addtitle>World Journal of Gastroenterology</addtitle><date>2017-08-28</date><risdate>2017</risdate><volume>23</volume><issue>32</issue><spage>5836</spage><epage>5848</epage><pages>5836-5848</pages><issn>1007-9327</issn><eissn>2219-2840</eissn><abstract>Clinical manifestations of inflammatory bowel disease(IBD) are not locally restricted to the gastrointestinal tract, and a significant portion of patients have involvement of other organs and systems. The visual system is one of the most frequently affected, mainly by inflammatory disorders such as episcleritis, uveitis and scleritis. A critical review of available literature concerning ocular involvement in IBD, as it appears in Pub Med, was performed. Episcleritis, the most common ocular extraintestinal manifestation(EIM), seems to be more associated with IBD activity when compared with other ocular EIMs. In IBD patients, anterior uveitis has an insidious onset, it is longstanding and bilateral, and not related to the intestinal disease activity. Systemic steroids or immunosuppressants may be necessary in severe ocular inflammation cases, and control of the underlying bowel disease is important to prevent recurrence. Our review revealed that ocular involvement is more prevalent in Crohn’s disease than ulcerative colitis, in active IBD, mainly in the presence of other EIMs. The ophthalmic symptoms in IBD are mainly nonspecific and their relevance may not be recognized by the clinician; most ophthalmic manifestations are treatable, and resolve without sequel upon prompt treatment. A collaborative clinical care team for management of IBD that includes ophthalmologists is central for improvement of quality care for these patients, and it is also cost-effective.</abstract><cop>United States</cop><pub>Baishideng Publishing Group Inc</pub><pmid>28932076</pmid><doi>10.3748/wjg.v23.i32.5836</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1007-9327
ispartof World journal of gastroenterology : WJG, 2017-08, Vol.23 (32), p.5836-5848
issn 1007-9327
2219-2840
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5583569
source MEDLINE; Baishideng "World Journal of" online journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection
subjects Gastroenterologists - organization & administration
Immunosuppressive Agents - therapeutic use
Inflammatory Bowel Diseases - complications
Inflammatory Bowel Diseases - drug therapy
Inflammatory Bowel Diseases - epidemiology
Intersectoral Collaboration
Ophthalmologists - organization & administration
Patient Care Team - organization & administration
Prevalence
Recurrence
Review
Scleritis - drug therapy
Scleritis - epidemiology
Scleritis - etiology
Uveitis - drug therapy
Uveitis - epidemiology
Uveitis - etiology
title Ophthalmic manifestations in patients with inflammatory bowel disease: a review
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T19%3A27%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ophthalmic%20manifestations%20in%20patients%20with%20inflammatory%20bowel%20disease:%20a%20review&rft.jtitle=World%20journal%20of%20gastroenterology%20:%20WJG&rft.au=Troncoso,%20Leandro%20Lopes&rft.date=2017-08-28&rft.volume=23&rft.issue=32&rft.spage=5836&rft.epage=5848&rft.pages=5836-5848&rft.issn=1007-9327&rft.eissn=2219-2840&rft_id=info:doi/10.3748/wjg.v23.i32.5836&rft_dat=%3Cproquest_pubme%3E1941368684%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1941368684&rft_id=info:pmid/28932076&rft_cqvip_id=90888889504849555150484851&rfr_iscdi=true